2018 FDA Tides Harvest

In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, three of them (5%) are TIDES (or also, -tides), two oligonucleotides and one peptide. Herein, the three TIDES approved are analyzed in terms of medical target, mode of action, chemical structure, and econ...

Full description

Bibliographic Details
Main Authors:	Danah Al Shaer, Othman Al Musaimi, Fernando Albericio, Beatriz G. de la Torre
Format:	Article
Language:	English
Published:	MDPI AG 2019-04-01
Series:	Pharmaceuticals
Subjects:	dotatate drugs inotersen Lutathera oligonucleotides Onpattro patisiran peptides pharmaceutical market Tegsedi
Online Access:	https://www.mdpi.com/1424-8247/12/2/52

id	doaj-c1e6d06cf639429bbf6a31b46d083d5b
record_format	Article
spelling	doaj-c1e6d06cf639429bbf6a31b46d083d5b2020-11-25T03:40:02ZengMDPI AGPharmaceuticals1424-82472019-04-011225210.3390/ph12020052ph120200522018 FDA Tides HarvestDanah Al Shaer0Othman Al Musaimi1Fernando Albericio2Beatriz G. de la Torre3KRISP, School of Laboratory of Medicine and Medical Science, College of Health Sciences, University of KwaZulu-Natal, Durban 4001, South AfricaKRISP, School of Laboratory of Medicine and Medical Science, College of Health Sciences, University of KwaZulu-Natal, Durban 4001, South AfricaSchool of Chemistry and Physics, University of KwaZulu-Natal, Durban 4001, South AfricaKRISP, School of Laboratory of Medicine and Medical Science, College of Health Sciences, University of KwaZulu-Natal, Durban 4001, South AfricaIn 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, three of them (5%) are TIDES (or also, -tides), two oligonucleotides and one peptide. Herein, the three TIDES approved are analyzed in terms of medical target, mode of action, chemical structure, and economics.https://www.mdpi.com/1424-8247/12/2/52dotatatedrugsinotersenLutatheraoligonucleotidesOnpattropatisiranpeptidespharmaceutical marketTegsedi
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Danah Al Shaer Othman Al Musaimi Fernando Albericio Beatriz G. de la Torre
spellingShingle	Danah Al Shaer Othman Al Musaimi Fernando Albericio Beatriz G. de la Torre 2018 FDA Tides Harvest Pharmaceuticals dotatate drugs inotersen Lutathera oligonucleotides Onpattro patisiran peptides pharmaceutical market Tegsedi
author_facet	Danah Al Shaer Othman Al Musaimi Fernando Albericio Beatriz G. de la Torre
author_sort	Danah Al Shaer
title	2018 FDA Tides Harvest
title_short	2018 FDA Tides Harvest
title_full	2018 FDA Tides Harvest
title_fullStr	2018 FDA Tides Harvest
title_full_unstemmed	2018 FDA Tides Harvest
title_sort	2018 fda tides harvest
publisher	MDPI AG
series	Pharmaceuticals
issn	1424-8247
publishDate	2019-04-01
description	In 2018, the United States Food and Drug Administration (FDA) approved a total of 59 new drugs, three of them (5%) are TIDES (or also, -tides), two oligonucleotides and one peptide. Herein, the three TIDES approved are analyzed in terms of medical target, mode of action, chemical structure, and economics.
topic	dotatate drugs inotersen Lutathera oligonucleotides Onpattro patisiran peptides pharmaceutical market Tegsedi
url	https://www.mdpi.com/1424-8247/12/2/52
work_keys_str_mv	AT danahalshaer 2018fdatidesharvest AT othmanalmusaimi 2018fdatidesharvest AT fernandoalbericio 2018fdatidesharvest AT beatrizgdelatorre 2018fdatidesharvest
_version_	1724536798622777344

2018 FDA Tides Harvest

Similar Items